Nanobiotix (NBTX) has released an update.
Nanobiotix, a Paris-headquartered biotech firm listed on Euronext Paris and Nasdaq, has disclosed its latest share capital and voting rights figures. As of May 31, 2024, the company has 47,133,328 shares outstanding and a total of 48,904,378 theoretical voting rights. Committed to pioneering innovative therapeutic approaches, Nanobiotix owns over 25 patent families across various nanotechnology platforms.
For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.
